GH secretagogues and uses thereof

Details for Australian Patent Application No. 2005297366 (hide)

Owner Theratechnologies Inc.

Inventors Gravel, Denis; Abribat, Thierry; Chapdelaine, Alcide; Allas, Soraya; De Villers, Andre

Agent Cullens

Pub. Number AU-B-2005297366

PCT Pub. Number WO2006/042408

Priority 10/969,463 20.10.04 US; 2,485,472 20.10.04 CA

Filing date 20 October 2005

Wipo publication date 27 April 2006

Acceptance publication date 8 December 2011

International Classifications

A61K 38/25 (2006.01) Medicinal preparations containing peptides - Growth hormone-releasing factor (GH-RF) (Somatoliberin)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/042408 Priority application(s): WO2006/042408

26 July 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 May 2007

8 December 2011 Application Accepted

  Published as AU-B-2005297366

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005297367-Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 CGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women

2005297362-Method for controlling insects of the Order Diptera using a Bacillus thuringiensis strain